Gw&K Investment Management, LLC Agios Pharmaceuticals, Inc. Transaction History
Gw&K Investment Management, LLC
- $11.8 Billion
- Q4 2024
A detailed history of Gw&K Investment Management, LLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Gw&K Investment Management, LLC holds 683,463 shares of AGIO stock, worth $22.8 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
683,463
Previous 630,946
8.32%
Holding current value
$22.8 Million
Previous $28 Million
19.89%
% of portfolio
0.19%
Previous 0.24%
Shares
4 transactions
Others Institutions Holding AGIO
# of Institutions
237Shares Held
57.1MCall Options Held
374KPut Options Held
394K-
Farallon Capital Management LLC San Francisco, CA5.66MShares$189 Million1.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.63MShares$188 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$162 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.74MShares$124 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.83MShares$94.3 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.83B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...